Min-Gi Cha
Overview
Explore the profile of Min-Gi Cha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang E, Cha M, Kwon G, Han S, Yoon S, Lee S, et al.
Microbiome
. 2024 Sep;
12(1):181.
PMID: 39342324
Backrground: Akkermansia muciniphila, a next-generation probiotic, is known as a cornerstone regulating the gut-organ axis in various diseases, but the underlying mechanism remains poorly understood. Here, we revealed the neuronal...
2.
Lee S, Gupta H, Min B, Ganesan R, Sharma S, Won S, et al.
Artif Cells Nanomed Biotechnol
. 2024 Apr;
52(1):250-260.
PMID: 38687561
Despite many recent studies on non-alcoholic fatty liver disease (NAFLD) therapeutics, the optimal treatment has yet to be determined. In this unfinished project, we combined secondary metabolites (SMs) from the...
3.
Cha M, Lee S, Yoon S, Lee S, Gupta H, Ganesan R, et al.
Clin Transl Sci
. 2024 Mar;
17(3):e13778.
PMID: 38515346
Persea americana fruit (PAF) is a favorable nutraceutical resource that comprises diverse unsaturated fatty acids (UFAs). UFAs are significant dietary supplementation, as they relieve metabolic disorders, including obesity (OB). In...
4.
Oh K, Gupta H, Ganesan R, Sharma S, Won S, Jeong J, et al.
Artif Cells Nanomed Biotechnol
. 2023 May;
51(1):217-232.
PMID: 37129458
We comprised metabolites of gut microbiota (GM; endogenous species) and dietary plant-derived natural flavonoids (DPDNFs; exogenous species) were known as potent effectors against non-alcoholic fatty liver disease (NAFLD) network pharmacology...
5.
Oh K, Choi I, Gupta H, Raja G, Sharma S, Won S, et al.
Artif Cells Nanomed Biotechnol
. 2022 Dec;
51(1):1-12.
PMID: 36562095
We intended to identify favourable metabolite(s) and pharmacological mechanism(s) of gut microbiota (GM) for liver regeneration (LR) through network pharmacology. We utilized the gutMGene database to obtain metabolites of GM,...
6.
Oh K, Gupta H, Min B, Ganesan R, Sharma S, Won S, et al.
Cells
. 2022 Sep;
11(18).
PMID: 36139478
The metabolites produced by the gut microbiota have been reported as crucial agents against obesity; however, their key targets have not been revealed completely in complex microbiome systems. Hence, the...
7.
Oh K, Choi Y, Gupta H, Ganesan R, Sharma S, Won S, et al.
Curr Issues Mol Biol
. 2022 Jul;
44(7):3253-3266.
PMID: 35877448
Alcoholic liver disease (ALD) is linked to a broad spectrum of diseases, including diabetes, hypertension, atherosclerosis, and even liver carcinoma. The ALD spectrum includes alcoholic fatty liver disease (AFLD), alcoholic...
8.
Gupta H, Min B, Ganesan R, Gebru Y, Sharma S, Park E, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327352
Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat globally, and has attracted growing concern in the research field of liver diseases. NAFLD comprises multifarious fatty...